Literature DB >> 10202985

Cytokine-induced inflammation and long-term stroke functional outcome.

N Vila1, X Filella, R Deulofeu, C Ascaso, R Abellana, A Chamorro.   

Abstract

Inflammatory reactions are involved in the pathogenesis of cerebral ischemia. Cytokines exacerbate brain ischemic injury by several mechanisms and they activate the synthesis of acute-phase reactants. We evaluated the association between cytokine-induced inflammation and functional outcome in 41 patients with acute ischemic stroke. Blood samples for interleukin-1 receptor antagonist (IL-1ra), erythrocyte sedimentation rate (ESR), c-reactive protein (CRP) and polymorphonuclear leukocyte (PMNL) count were taken within 48 h from stroke onset. Functional outcome was assessed at six months with the Modified Rankin Scale. Patients with a Rankin score > or = 3 were classified as dependent outcome. The effect of inflammatory variables on outcome was analyzed by logistic regression. Mathew score <75 on admission, atrial fibrillation, non-lacunar infarct size, ESR>13 mm/h in men or >20 mm/h in women, PMNL count >8 x 10(9)/l, CRP>0.8 mg/dl and IL-1ra>500 pg/ml were associated with dependent outcome. On multiple logistic regression, severe stroke on admission, non-lacunar infarct size and ESR remain in the predictive model of outcome with a sensitivity and specificity of 76 and 80%, respectively. This study suggests that in addition to clinical evaluation and neuroimaging, measurement of ESR may be useful for the early detection of stroke patients with poor long-term functional outcome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10202985     DOI: 10.1016/s0022-510x(98)00319-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  17 in total

1.  Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke.

Authors:  A Chamorro; S Amaro; M Vargas; V Obach; A Cervera; F Torres; A M Planas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11       Impact factor: 10.154

Review 2.  Blood/Brain Biomarkers of Inflammation After Stroke and Their Association With Outcome: From C-Reactive Protein to Damage-Associated Molecular Patterns.

Authors:  Alejandro Bustamante; Alba Simats; Andrea Vilar-Bergua; Teresa García-Berrocoso; Joan Montaner
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

3.  Classical and additional antiphospholipid antibodies in blood samples of ischemic stroke patients and healthy controls.

Authors:  Narin-Nard Carmel-Neiderman; David Tanne; Idan Goren; Pnina Rotman-Pikielny; Yair Levy
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

4.  Neopterin levels in patients with cerebrovascular disease.

Authors:  Hizir Ulvi; Habib Emre; Recep Demir; Recep Aygul; Asuman Varoğlu; Fatih Kara
Journal:  Eurasian J Med       Date:  2008-08

Review 5.  The immune system in stroke: clinical challenges and their translation to experimental research.

Authors:  Craig J Smith; Catherine B Lawrence; Beatriz Rodriguez-Grande; Krisztina J Kovacs; Jesus M Pradillo; Adam Denes
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-15       Impact factor: 4.147

6.  Plasma proinflammatory and anti-inflammatory cytokine and catecholamine concentrations as predictors of neurological outcome in acute stroke patients.

Authors:  Jun Oto; Atsuhiko Suzue; Daisuke Inui; Yasushi Fukuta; Kikumi Hosotsubo; Mayumi Torii; Shinji Nagahiro; Masaji Nishimura
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078

Review 7.  Chinese medicines and bioactive compounds for treatment of stroke.

Authors:  Thanasekaran Jayakumar; Antoinet Ramola Elizebeth; Ting-lin Yen; Joen-rong Sheu
Journal:  Chin J Integr Med       Date:  2014-07-10       Impact factor: 1.978

Review 8.  Cerebral small vessel disease: genetic risk assessment for prevention and treatment.

Authors:  Ada Lam; M Anne Hamilton-Bruce; Jim Jannes; Simon A Koblar
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

9.  Monocytes and monocyte chemoattractant protein 1 (MCP-1) as early predictors of disease outcome in patients with cerebral ischemic stroke.

Authors:  David Bonifačić; Adrian Toplak; Indira Benjak; Vlatka Sotošek Tokmadžić; Andrica Lekić; Natalia Kučić
Journal:  Wien Klin Wochenschr       Date:  2015-11-05       Impact factor: 1.704

10.  Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke.

Authors:  Guanglin Cui; Haoran Wang; Rui Li; Lina Zhang; Zongzhe Li; Yan Wang; Rutai Hui; Hu Ding; Dao Wen Wang
Journal:  J Neuroinflammation       Date:  2012-10-10       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.